Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

Clinical trial NCT00422955 · COMPLETED

Trial details

NCT number: NCT00422955
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuropathy, Diabetic

Start date: 2003-11-01
Primary completion: 2005-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.